Get complete access to comprehensive company data for Goldencross Pharma Limited.
Complete Report
One-time • Full access
Credit Plan
Pay as you go • Instant
Processing your request...
Downloading your report...
Success
Request Company Screening
Goldencross Pharma Limited
Once your screening request is processed, you will receive a notification and the complete report will be available in PDF format for download from your account dashboard.
₹ 4.00 cr
₹ 0.05 cr
21 Jan 2000
31 Mar 2023
Goldencross Pharma Limited is an Indian public limited company incorporated on 21 Jan 2000. The company's registered office is situated in Mumbai, Maharashtra, India.
The current status of Goldencross Pharma Limited is Active. The company has filed its annual returns and financial statements up to 31 Mar 2023 (FY 2022-2023).
Goldencross Pharma Limited is a company limited by shares with an authorized capital of ₹4.00 cr and a paid-up capital of ₹0.05 cr as per the records maintained by the Ministry of Corporate Affairs (MCA).
Goldencross Pharma Limited has 4 directors and 2 signatories. The Key Managerial Personnel (KMP) at Goldencross Pharma Limited include Chirag Hotchandani as Company Secretary and Pantha Milan Kundu as CFO. The directors of the company include Rajendra Kumar Chopra, Swapn Bhawani Malpani, Ujjwal Prakash Shendre, Anisha Naresh Udeshi.
The registered office of Goldencross Pharma Limited is located at Tower A, 1St Floor, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai Maharashtra 400013 India in Mumbai, Maharashtra, India.
- CIN/LLPIN/FCRN: U24239MH2000PLC123766
- Legal Name: Goldencross Pharma Limited
- ROC Code: Roc Mumbai
- Company No.: 123766
- Company Category: Company Limited By Shares
- Company Sub Category: Non-Government Company
- Company Class: Public
- Listing Status: Unlisted
- Industry: Pharma
- Date of AGM: 22 Sep 2023
🔒 14.3%
(FY 202_)🔒 8.9%
(FY 202_)🔒 12.7%
(FY 202_)🔒 9.5%
(FY 202_)🔒 11.8%
(FY 202_)🔒 15.2%
(FY 202_)🔒 10.6%
(FY 202_)🔒 13.4%
(FY 202_)
Financial Performance Overview
| Financial Metric | FY 2023 | Growth | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Total Revenue | 12,45,67,890 | +191.42% | 4,26,78,123 | 3,89,45,234 | 2,98,12,456 | 2,15,67,890 |
| Revenue from Operations | 11,98,45,678 | +176.82% | 4,32,10,987 | 3,78,90,123 | 2,89,45,678 | 2,10,23,456 |
| Total Assets | 45,67,89,012 | +61.07% | 28,34,56,789 | 24,56,78,901 | 19,87,65,432 | 16,54,32,109 |
| Profit or Loss | -1,23,45,678 | 24.56% | 4,32,109 | 2,15,678 | 1,89,234 | 1,23,456 |
| Net Worth | 12,34,56,789 | 85.66% | 85,67,89,012 | 78,90,12,345 | 65,43,21,098 | 54,32,10,987 |
| EBITDA | 2,34,56,789 | +6604.87% | 3,49,012 | 2,10,987 | 1,56,789 | 98,765 |
| Past Director Details of Goldencross Pharma Limited |
|---|
Frequently Asked Questions
- anisha naresh udeshi
- chirag hotchandani
- pantha milan kundu
- rajendra kumar chopra
- swapn bhawani malpani
- ujjwal prakash shendre